Bristol Myers Squibb and Microsoft have launched a digital health collaboration aimed at accelerating early detection of lung cancer using AI-driven radiology workflows.
The initiative will deploy FDA-cleared algorithms through Microsoft’s Precision Imaging Network, which is used by more than 80% of U.S. hospitals, according to a Jan. 16 news release from Bristol Myers Squibb. The workflow management tools are analyze X-ray and CT images, help detect lung nodules and identify early-stage disease, and support patient tracking through care pathways.
The collaboration aims to reduce diagnostic delays, improve operational efficiency and expand early detection access in medically underserved communities, including rural clinics.
Leaders said the partnership leverages Bristol Myers Squibb’s oncology expertise and Microsoft’s AI infrastructure.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
